Summary:
Study to Evaluate the Safety and Contraceptive Efficacy of the Study Drug in Women with Uterine Fibroids or Endometriosis who are at Risk for Pregnancy.
Qualified Participants Must:
• Have a Diagnosis of Uterine Fibroids OR Have a Diagnosis of endometriosis and has had surgical or direct visualization and/or histopathologic confirmation of endometriosis
Qualified Participants May Receive:
$100 to $150 Per in Person Visit.